XBIO (STOCKS)
Xenetic Biosciences, Inc.
$3.290000
-0.010000 (-0.30%)
Prev close: $3.300000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- James F. Parslow
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $9.48M
- Employees
- 2
- P/E (TTM)
- -2.77
- P/B (TTM)
- 1.27
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $3.26M |
| Benefits Costs and Expenses | $0.00 |
| Costs And Expenses | $5.90M |
| Nonoperating Income/Loss | $166.48K |
| Operating Expenses | $5.90M |
| Research and Development | $2.74M |
| Other Operating Expenses | $3.16M |
| Operating Income/Loss | -$2.64M |
| Income/Loss From Continuing Operations After Tax | -$2.48M |
| Income/Loss From Continuing Operations Before Tax | $3.26M |
| Income Tax Expense/Benefit | $0.00 |
| Net Income/Loss | -$2.48M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$2.48M |
| Net Income/Loss Available To Common Stockholders, Basic | -$2.48M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$1.16 |
| Diluted Earnings Per Share | -$1.16 |
| Basic Average Shares | 6,286,991 |
| Diluted Average Shares | 6,286,991 |
| Assets | $6.97M |
| Current Assets | $6.65M |
| Noncurrent Assets | $313.92K |
| Liabilities | $894.98K |
| Current Liabilities | $894.98K |
| Accounts Payable | $322.54K |
| Other Current Liabilities | $572.44K |
| Noncurrent Liabilities | $0.00 |
| Equity | $6.07M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $6.07M |
| Liabilities And Equity | $6.97M |
| Net Cash Flow From Operating Activities | -$2.31M |
| Net Cash Flow From Operating Activities, Continuing | -$2.31M |
| Net Cash Flow | -$26.14K |
| Net Cash Flow, Continuing | -$26.14K |
| Comprehensive Income/Loss | -$2.48M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$2.48M |
| Other Comprehensive Income/Loss | $0.00 |